Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fetal globin gene expression refers to the transcription and translation of the γ-globin genes (HBG1 and HBG2), which are highly active during fetal development. These genes encode the gamma chains of fetal hemoglobin (HbF, α2γ2), which predominates in the fetus and is gradually replaced by adult hemoglobin (HbA, α2β2) after birth. The switch from fetal to adult globin gene expression is a tightly regulated developmental process. Reactivation of fetal globin gene expression is a therapeutic strategy for disorders like sickle cell disease and β-thalassemia.
Hydroxyurea reduces repressors' levels leading to increased HbF synthesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fetal Globin Gene Expression (HbF Expression).